Skip to main content
. 2018 Sep 7;8:13442. doi: 10.1038/s41598-018-31713-x

Figure 6.

Figure 6

In vivo biodistribution study of HAdV17GFP vectors. Viral genomes were measured by qPCR in liver, heart, lung, artery, kidney, pancreas, spleen, intestine and brain 72hrs after systemic administration. 2 × 10e9 transducing units (TU) per mouse of HAdV17GFP were administered intravenously into CD46 transgenic mice and wild type C57BL/6 mice, and the same viral dose of HAdV5GFP was injected into wild type mice serving as control (n = 3 mice per group). (A) Direct comparison of HAdV17GFP and HAdV5GFP in C57CBl/6 wild type mice. (B) Direct comparison of HAdV17GFP in CD46 transgenic and wild type mice. *P < 0.05, **P < 0.01, ***P < 0.001. (C) Neutralizing antibody assay. Reciprocal dilution of dog serum, immunized with HAdV5, was incubated with HAdV17GFP and HAdV5GFP. The serum-virus mixture was used to infect HEK293 cells and 24 hrs post-infection GFP expression levels were determined. **P < 0.01, ***P < 0.001.